Related Experiment Videos
Tricuspid atresia: current concepts in diagnosis and treatment
Insights
Tricuspid atresia, a common congenital heart defect, is often treated with a Fontan operation. This surgical procedure connects systemic venous return to the pulmonary arteries, yielding very good long-term results.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Cardiac Surgery
Background:
- Tricuspid atresia is the third most frequent cyanotic cardiac malformation.
- It affects approximately 1% of pediatric patients with congenital heart disease.
- Echocardiography is crucial for elucidating patient-specific anatomy.
Purpose of the Study:
- To review the diagnostic and therapeutic strategies for tricuspid atresia.
- To highlight the efficacy of the Fontan operation for definitive treatment.
Main Methods:
- Initial surgical palliation typically involves an aortopulmonary shunt.
- Definitive surgical correction is achieved through the Fontan operation.
- Echocardiography is used for detailed anatomical assessment.
Main Results:
- The Fontan operation connects systemic venous return directly to the pulmonary arterial tree.
- Long-term outcomes following the Fontan procedure are very good.
Conclusions:
- Tricuspid atresia requires staged surgical management, starting with palliation.
- The Fontan operation represents an effective definitive treatment for tricuspid atresia.
- Excellent long-term results support the Fontan operation's role in managing this condition.
Abstract:
Tricuspid atresia is the third most common cyanotic cardiac malformation, seen in 1 per cent of children with congenital heart disease. Anatomic details in each patient can be elucidated by echocardiography. Surgical treatment initially is palliation, usually with aortopulmonary shunt. Definitive treatment is with a Fontan operation, in which the systemic venous return is connected directly to the pulmonary arterial tree. Long-term results of the corrective procedure have been very good.